European Patent Office

T 0785/05 vom 18.12.2007

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2007:T078505.20071218
Datum der Entscheidung
18. Dezember 2007
Aktenzeichen
T 0785/05
Antrag auf Überprüfung von
-
Anmeldenummer
99968778.3
IPC-Klasse
C08B 37/08
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Cross-linked hyaluronic acids and medical uses thereof
Name des Antragstellers
Sigmar Italia S.p.A.
Name des Einsprechenden
Fidia Farmaceutici S.P.A.
Kammer
3.3.03
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 100(a) 1973European Patent Convention Art 111(1)European Patent Convention Art 52(1) 1973European Patent Convention Art 54European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention R 116(1)European Patent Convention R 71a(1) 1973Rules of procedure of the Boards of Appeal Art 10a(1)(a)Rules of procedure of the Boards of Appeal Art 10a(1)(b)Rules of procedure of the Boards of Appeal Art 10a(2)Rules of procedure of the Boards of Appeal Art 10b(1)Rules of procedure of the Boards of Appeal Art 10b(3)Rules of procedure of the Boards of Appeal Art 12(1)(a)Rules of procedure of the Boards of Appeal Art 12(1)(b)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
Schlagwörter
Novelty - yes
Amendment to a Party's Case
Decision re-appeals - remittal (yes)
Orientierungssatz
-
Zitierte Akten
T 1002/92
Zitierende Akten
T 0365/09

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance for further prosecution on the basis of the Main Request filed with letter dated 19 October 2007.